An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
出版年份 2022 全文链接
标题
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 11, Issue 9, Pages 2302
出版商
MDPI AG
发表日期
2022-04-21
DOI
10.3390/jcm11092302
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology
- (2022) Fabio Salvatore Macaluso et al. DIGESTIVE AND LIVER DISEASE
- Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
- (2021) Séverine Vermeire et al. Journal of Crohns & Colitis
- ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
- (2021) T Kucharzik et al. Journal of Crohns & Colitis
- Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry
- (2021) María Chaparro et al. Journal of Crohns & Colitis
- Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study
- (2021) Mathurin Fumery et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
- (2021) Brian G Feagan et al. LANCET
- 5-Aminosalicylic Acid Chemoprevention in Inflammatory Bowel Diseases: Is It Necessary in the Age of Biologics and Small Molecules?
- (2021) Hans Herfarth et al. Inflammatory Intestinal Diseases
- ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
- (2021) Tim Raine et al. Journal of Crohns & Colitis
- Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
- (2021) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study
- (2021) Silvio Danese et al. Lancet Gastroenterology & Hepatology
- Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis
- (2020) Pablo Olivera et al. GASTROENTEROLOGY
- Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
- (2020) William J. Sandborn et al. GASTROENTEROLOGY
- Comparative of the Effectiveness and Safety of Biological Agents, Tofacitinib, and Fecal Microbiota Transplantation in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
- (2020) Hao-Yue Zhou et al. IMMUNOLOGICAL INVESTIGATIONS
- Switching From Originator Adalimumab to the Biosimilar SB5 in Patients With Inflammatory Bowel Disease: Short-term Experience From a Single Tertiary Clinical Centre
- (2020) Martin Lukas et al. Journal of Crohns & Colitis
- REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY.
- (2020) Brigida Barberio et al. DIGESTIVE DISEASES
- TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
- (2020) Marianne Vulliemoz et al. DIGESTION
- Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
- (2020) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
- (2019) Gionata Fiorino et al. DIGESTIVE AND LIVER DISEASE
- Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis
- (2019) Carlos Taxonera et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Role of Early Biologic Therapy in Inflammatory Bowel Disease
- (2019) Dana Rachel Berg et al. INFLAMMATORY BOWEL DISEASES
- Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
- (2019) Aurelien Amiot et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis
- (2019) Gerd R. Burmester et al. ADVANCES IN THERAPY
- Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients
- (2019) Christian P. Selinger et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open
- (2019) Bruce E. Sands et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data
- (2019) Timothy Card et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Decreasing Colectomy Rate for Ulcerative Colitis in the United States Between 2007 and 2016: A Time Trend Analysis
- (2019) Edward L Barnes et al. INFLAMMATORY BOWEL DISEASES
- Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis
- (2019) Thomas Ochsenkühn et al. United European Gastroenterology Journal
- Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
- (2018) P. Wils et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
- (2018) Caitriona Ryan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-α-Directed Therapy for Inflammatory Bowel Disease
- (2018) James D Lewis et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
- (2018) Stefanos Bonovas et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn’s Disease or Ulcerative Colitis: a Systematic Review and Meta-analysis
- (2018) Laurent Peyrin-Biroulet et al. Clinical Gastroenterology and Hepatology
- Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
- (2018) Amy Hemperly et al. CLINICAL PHARMACOKINETICS
- Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study
- (2018) Carl Eriksson et al. GUT
- Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical Implications
- (2018) Hanna M J L Hazenberg et al. INFLAMMATORY BOWEL DISEASES
- Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
- (2018) Joseph Meserve et al. Clinical Gastroenterology and Hepatology
- Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis
- (2018) Antonio Tursi et al. MEDICINE
- Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
- (2018) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- American Gastroenterological Association Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
- (2018) Siddharth Singh et al. GASTROENTEROLOGY
- American Gastroenterological Association Institute Guideline on the Management of Mild-to-Moderate Ulcerative Colitis
- (2018) Cynthia W. Ko et al. GASTROENTEROLOGY
- Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies
- (2018) Julian Panés et al. Journal of Crohns & Colitis
- Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study
- (2017) Chang-Ho Ryan Choi et al. GUT
- Systematic Review and Meta-analysis
- (2017) Jean M. Chalhoub et al. INFLAMMATORY BOWEL DISEASES
- A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease
- (2017) Ditte V Mogensen et al. Journal of Crohns & Colitis
- Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
- (2017) David T. Rubin et al. Journal of Crohns & Colitis
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
- (2017) Glen Doherty et al. Journal of Crohns & Colitis
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
- (2017) Fernando Magro et al. Journal of Crohns & Colitis
- Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- (2017) Sudarshan Paramsothy et al. Journal of Crohns & Colitis
- A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis
- (2017) Taku Kobayashi et al. JOURNAL OF GASTROENTEROLOGY
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD
- (2017) Brigitte Moreau et al. Therapeutic Advances in Gastroenterology
- Steroid dependency and trends in prescribing for inflammatory bowel disease - a 20-year national population-based study
- (2016) V. Chhaya et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
- (2016) Paweł Kawalec et al. Archives of Medical Science
- Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
- (2016) Shailja C. Shah et al. Clinical Gastroenterology and Hepatology
- Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
- (2016) William J. Sandborn et al. CURRENT MEDICAL RESEARCH AND OPINION
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease
- (2016) M. Severs et al. Journal of Crohns & Colitis
- An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
- (2016) Tim Wyant et al. Journal of Crohns & Colitis
- Treatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review
- (2016) Zi Jian Luan et al. Journal of Digestive Diseases
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis
- (2016) Xinyun Qiu et al. Oncotarget
- Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study
- (2016) Christopher Ma et al. Canadian Journal of Gastroenterology and Hepatology
- Mesalazine in Inflammatory Bowel Disease: A Trendy Topic Once Again?
- (2016) Marietta Iacucci et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease: A Canadian Burden of Illness Review
- (2016) Angela Rocchi et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
- (2015) Gert Van Assche et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
- (2015) L Peyrin-Biroulet et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Concentrations of 6-Thioguanine Nucleotide Correlate With Trough Levels of Infliximab in Patients With Inflammatory Bowel Disease on Combination Therapy
- (2015) Andres J. Yarur et al. Clinical Gastroenterology and Hepatology
- Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Azathioprine and 6-Mercaptopurine: A Meta-analysis
- (2015) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Granulocyte/Monocyte Adsorptive Apheresis in Moderate to Severe Ulcerative Colitis - Effective or Not?
- (2015) Wolfgang Kruis et al. DIGESTION
- A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease
- (2015) Andrea Michielan et al. DIGESTIVE AND LIVER DISEASE
- Efficacy of tumour necrosis factor antagonists on remission, colectomy and hospitalisations in ulcerative colitis: Meta-analysis of placebo-controlled trials
- (2015) Anthony Lopez et al. DIGESTIVE AND LIVER DISEASE
- Ulcerative Colitis Care Pathway
- (2015) Themistocles Dassopoulos et al. GASTROENTEROLOGY
- Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis
- (2015) Sanjay K. Murthy et al. INFLAMMATORY BOWEL DISEASES
- Infliximab-Related Infusion Reactions: Systematic Review
- (2015) Lev Lichtenstein et al. Journal of Crohns & Colitis
- European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
- (2015) Vito Annese et al. Journal of Crohns & Colitis
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Biologics for Extraintestinal Manifestations of IBD
- (2014) Stephan Vavricka et al. CURRENT DRUG TARGETS
- Can We Predict the High-Risk Patient?
- (2014) Jose-Manuel Benitez et al. DIGESTIVE DISEASES
- European evidence based consensus on surgery for ulcerative colitis
- (2014) Tom Øresland et al. Journal of Crohns & Colitis
- A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: Treatment outcomes of 847 patients in clinical practice
- (2014) Yoko Yokoyama et al. Journal of Crohns & Colitis
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Ulcerative Colitis
- (2014) Joseph D. Feuerstein et al. MAYO CLINIC PROCEEDINGS
- A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
- (2014) Suk-Kyun Yang et al. NATURE GENETICS
- Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)
- (2014) Anne C Seagrove et al. BMJ Open
- Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab
- (2013) A. Croft et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis
- (2013) B. Flourié et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Risk Factors for Complicated Disease: How Reliable Are They?
- (2013) Camille Zallot et al. DIGESTIVE DISEASES
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
- (2013) Simon P L Travis et al. GUT
- Safety of Thiopurine Therapy in Inflammatory Bowel Disease
- (2013) María Chaparro et al. INFLAMMATORY BOWEL DISEASES
- Duration of Disease May Predict Response to Infliximab in Pediatric Ulcerative Colitis
- (2013) Sabina A.V. Mir et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Tolerability of one hour 10mg/kg infliximab infusions in inflammatory bowel diseases: A prospective multicenter cohort study
- (2013) Abdenour Babouri et al. Journal of Crohns & Colitis
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients
- (2013) William Zabala et al. PHARMACOGENOMICS
- Systematic review: antibodies and anti-TNF-α levels in inflammatory bowel disease
- (2012) M. Chaparro et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort
- (2012) Laura E Targownik et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis
- (2012) Debanjali Mitra et al. BMC GASTROENTEROLOGY
- Second-Generation Corticosteroids for the Treatment of Crohns Disease and Ulcerative Colitis: More Effective and Less Side Effects?
- (2012) Chiara De Cassan et al. DIGESTIVE DISEASES
- Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study
- (2012) William J. Sandborn et al. GASTROENTEROLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- (2012) David Laharie et al. LANCET
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: loss of response to anti-TNF treatments in Crohn’s disease
- (2011) S. Ben-Horin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study
- (2011) T. W. Lee et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing - ASCEND I and II combined analysis
- (2011) G. R. Lichtenstein et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis
- (2011) Xavier Roblin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Severity of Inflammation as a Predictor of Colectomy in Patients With Chronic Ulcerative Colitis
- (2011) Marco M. Hefti et al. DISEASES OF THE COLON & RECTUM
- Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
- (2011) Harminder Singh et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study
- (2011) Mats Sjöberg et al. INFLAMMATORY BOWEL DISEASES
- Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence
- (2011) Joana Torres et al. INFLAMMATORY BOWEL DISEASES
- A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy and Hospitalization
- (2010) Abderrahim Oussalah et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis
- (2010) William J. Sandborn et al. GASTROENTEROLOGY
- Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
- (2009) J. P. GISBERT et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
- (2009) M J L Romberg-Camps et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan
- (2009) T. Hibi et al. DIGESTIVE AND LIVER DISEASE
- Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
- (2009) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial
- (2008) Robert D. Inman et al. ARTHRITIS AND RHEUMATISM
- Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker
- (2008) S. Danese DIGESTIVE AND LIVER DISEASE
- MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis
- (2008) Mary Y Hu et al. EXPERT OPINION ON PHARMACOTHERAPY
- European evidence-based Consensus on the management of ulcerative colitis: Special situations
- (2008) Livia Biancone et al. Journal of Crohns & Colitis
- Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
- (2008) Inger Camilla Solberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started